[Inotropic treatment in heart transplantation].
The safe conduct of anesthesia and intensive care for heart transplant recipient requires a sound understanding of the pathophysiology of advanced cardiac failure through knowledge of anesthetic and cardiovascular pharmacology and an appreciation of the altered physiologic and pharmacologic responses of acutely denervated and transplanted heart. The most serious dysfunction is acute distension and failure of the transplanted heart's right ventricle. Hemodynamic monitoring and TEE are useful in the management of inotropic support during heart transplantation.
Giordano
F
F
Servizio di Anestesia e Rianimazione 2o Ospedale Civile, Udine.
Muzzi
R
R
D000758:Anesthesia; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D003422:Critical Care; D006333:Heart Failure / Q000188:drug therapy*; D016027:Heart Transplantation / Q000502:physiology*; D006801:Humans; D008991:Monitoring, Physiologic; D011183:Postoperative Complications / Q000188:drug therapy*; D016278:Ventricular Function, Right / Q000502:physiology
D002316:Cardiotonic Agents
Trattamento inotropico nel trapianto cardiaco.